Top Markets
Coin of the day
Lysogene S.A. Lysogene S.A.

Lysogene S.A.

LYS
Rankning i aktier #36618
Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy,... Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy, dedicated to discovering and advancing treatments for children affected by severe neurodegenerative lysosomal storage disorders. Its development pipeline includes LYS-SAF302, which is currently undergoing Phase II/III clinical trials for mucopolysaccharidosis type IIIA (MPS IIIA). Another promising candidate, LYS-GM101, is in Phase I/II development, targeting GM1 gangliosidosis. The company has also forged a research alliance with the Weizmann Institute of Science to pioneer novel adeno-associated virus (AAV) gene therapy approaches for conditions such as neuronopathic Gaucher disease, Parkinson's disease, and other related illnesses. Lysogene S.A. was established in 2009 and is headquartered in Neuilly-sur-Seine, France.
Aktiekurs
$0.30221445
Senast synkroniserad: 2023-05-22
Marknadsvärde
$2.49M
Förändring (1 dag)
-0.10%
Förändring (1 år)
0.00%
Land
FR
Handel Lysogene S.A. (LYS)

Kategori

Aktiekurshistorik för Lysogene S.A. (LYS)
Högsta slutkurs: $0.31 den 2023-05-01

Lägsta slutkurs: $6.58 den 2017-02-01
Aktiekurshistorik för Lysogene S.A. från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 -33.14%
2022 -79.09%
2021 -20.07%
2020 47.25%
2019 3.66%
2018 -62.69%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE